Literature DB >> 30735200

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells.

Michel Jourdan1, Hugues de Boussac1, Elena Viziteu1, Alboukadel Kassambara1, Jérôme Moreaux2.   

Abstract

Plasma cells (PCs) secrete large amounts of antibodies and develop from B cells that have been activated. PCs are rare cells located in the bone marrow or mucosa and ensure humoral immunity. Due to their low frequency and location, the study of PCs is difficult in human. We reported a B to PC in vitro differentiation model using selected combinations of cytokines and activation molecules that allow to reproduce the sequential cell differentiation occurring in vivo. In this in vitro model, memory B cells (MBCs) will differentiate into pre-plasmablasts (prePBs), plasmablasts (PBs), early PCs and finally, into long-lived PCs, with a phenotype close to their counterparts in healthy individuals. We also built an open access bioinformatics tools to analyze the most prominent information from GEP data related to PC differentiation. These resources can be used to study human B to PC differentiation and in the current study, we investigated the gene expression regulation of epigenetic factors during human B to PC differentiation.

Entities:  

Mesh:

Year:  2019        PMID: 30735200     DOI: 10.3791/58929

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  2 in total

1.  Human IgA-Expressing Bone Marrow Plasma Cells Characteristically Upregulate Programmed Cell Death Protein-1 Upon B Cell Receptor Stimulation.

Authors:  Annika Wiedemann; Marie Lettau; Ina Wirries; Annemarie Jungmann; Abdulrahman Salhab; Gilles Gasparoni; Henrik E Mei; Carsten Perka; Jörn Walter; Andreas Radbruch; Andreia C Lino; Thomas Dörner
Journal:  Front Immunol       Date:  2021-02-12       Impact factor: 7.561

2.  High-Throughput Detection of Autoantigen-Specific B Cells Among Distinct Functional Subsets in Autoimmune Donors.

Authors:  Bryan A Joosse; James H Jackson; Alberto Cisneros; Austin B Santhin; Scott A Smith; Daniel J Moore; Leslie J Crofford; Erin M Wilfong; Rachel H Bonami
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.